Spirometer Market Report 2026

Spirometer Market Overview

• Spirometer market size has reached to $1.27 billion in 2025 • Expected to grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Surge In Chronic Respiratory Diseases Drives Demand For Spirometer Market • Market Trend: Technological Advancements Propel Spirometer Market With Wireless Solutions • North America was the largest region in 2025.

What Is Covered Under Spirometer Market?

A spirometer refers to equipment that is used to assess lung health by measuring the amount of air that can be inhaled and exhaled by a person and the duration taken while exhaling the air. These are used to diagnose asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect breathing. The main types of spirometer include hand-held, tabletop, and desktop. The hand held spirometers are used for longitudinal epidemiological studies to measure and track the forced expiratory volume. The handheld segment of the spirometer market refers to a method of testing the lungs at home without the need for a doctor's visit. The main technologies used in a spirometer include volume measurement, flow measurement, and peak flow measurement. Products include the device, consumables, accessories, and software. The device is used in asthma, COPD, cystic fibrosis, pulmonary fibrosis, and other applications that are used across hospitals, clinics, and home healthcare.

What Is The Spirometer Market Growth Forecast?

The spirometer market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory monitoring, rising demand for telehealth-enabled diagnostics, growing investments in digital healthcare infrastructure, increasing focus on early disease detection, expansion of software-integrated spirometry platforms. Major trends in the forecast period include increasing adoption of digital and connected spirometers, rising integration of software-based lung function analysis, growing use of portable and handheld spirometers, expansion of remote respiratory monitoring capabilities, enhanced focus on diagnostic accuracy and standardization.

Global Spirometer Market Segmentation

1) By Type: Handheld, Table Top, Desktop 2) By Technology: Volume Measurement, Flow Measurement 3) By Application: Asthma, COPD, Cystic Fibrosis, Pulmonary Fibrosis, Other Applications 4) By End-Use: Hospitals And Clinics, Home Healthcare Subsegments: 1) By Hand-held: Digital Hand-held Spirometers, Mechanical Hand-held Spirometers 2) By Table Top: Electronic Table Top Spirometers, Ultrasonic Table Top Spirometers 3) By Desktop: Digital Desktop Spirometers, Software-Integrated Desktop Spirometers

What Is The Driver Of The Spirometer Market?

The increase in the prevalence of chronic respiratory diseases is expected to drive the demand for spirometer market going forward. Chronic respiratory diseases are chronic condition of the airways and other parts of the lung such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung diseases. Chronic respiratory diseases are attributed to factors such as smoking, air pollution, occupational exposures, and genetic predisposition. Spirometers help treat chronic respiratory diseases by measuring lung function, allowing doctors to monitor disease progression and treatment effectiveness. This information aids in adjusting medications and developing personalized care plans, ultimately enhancing patients' respiratory health. For instance, in November 2024, according to the Australian Institute of Health and Welfare, an Australian government agency, the respiratory conditions disease group contributed 7.2% to the overall disease burden, 8.5% to illnesses that cause disability without causing death, and 5.8% to premature deaths in 2023. Therefore, the increase in prevalence of chronic respiratory diseases is increasing demand for spirometer industry.

Key Players In The Global Spirometer Market

Major companies operating in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.

Global Spirometer Market Trends and Insights

Major companies operating in the spirometer market are focused on developing innovative solutions such as app-based platforms to help users track lung health and share data with healthcare providers. App-based platforms in the spirometer market enable users to monitor their lung function, receive real-time feedback, and share data with healthcare professionals for improved management of respiratory conditions. For instance, in May 2023, CMI Health Inc., a US-based medical equipment manufacturing company, launched AsthmaGo. AsthmaGo is an innovative app-based asthma management platform that integrates the SpiroLink digital spirometer, allowing users to conveniently monitor lung performance and oxygen levels from home. This platform empowers asthma patients, including children, to manage their condition effectively and share health data with caregivers for personalized care.

What Are Latest Mergers And Acquisitions In The Spirometer Market?

In January 2023, CAIRE Inc., a US-based company that manufactures oxygen therapy and on-site oxygen generation systems, acquired MGC Diagnostics Holdings, Inc. for an undisclosed amount. Through this acquisition, CAIRE aims to expand its clinical healthcare portfolio by integrating diagnostic technologies, enabling holistic care for patients throughout the progression of pulmonary disease. MGC Diagnostics Holdings Inc. is a US-based company providing cardiorespiratory diagnostic systems, including spirometers, body plethysmographs, cardiopulmonary exercise systems, flow sensors, gas analyzers, and related consumables.

Regional Outlook

North America was the largest region in the spirometer market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Spirometer Market?

The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.